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A reflection on Fukushima nuclear disaster: View of Taiwan doctorOn 11 March 2011, the Fukushima nuclear disaster
shocked the world. A 9.0 magnitude earthquake induced
a tsunami, which then shut down the power supply of cooling
system of the nuclear plant. The nuclear reactor exploded due
to overheat and hydrogen accumulation. Radioactive mate-
rials were released and plutonium was detected positive in the
soil of the power plant. It is the most severe nuclear accident
after the Chernobyl event. According to the nuclear safety
agency of Japanese government, Fukushima Daiichi nuclear
disaster was a level-7 event, the same as Chernobyl disaster.
Taiwan, although 2000 kilometers away from Japan, is still
under the threat of radiation exposure. Being doctors, it is our
responsibility to understand the management of radiation
exposure and to educate people.
The radiation effect on human varies with the exposure
dosage. When the exposure dosage is less than 500 mSv
(millisievert), there are no symptoms, but white blood cell
count decreases. Symptoms of fatigue, vomiting, poor appetite,
transient hair loss, and decreased red blood cell are developed
when human is exposed to 1000e2000 mSv dosage. Between
2000e4000 mSv dosage, exposure induces bone marrow
damage, and granulocytopenia or aplastic anemia may occur.
Exposure doses higher than 4000 mSv cause human death
directly.1
Among the main products of nuclear fission, the radioactive
iodine isotopes including I131 and I132 are the targets of stable
iodine protection. The protection are against two kinds of
radiation effect: deterministic effect and stochastic effect.2
Deterministic effects are caused by high level of radiation
exposure, and people in the vicinity of nuclear accident are at
the greatest risk. These iodine isotopes will be concentrated in
the thyroid gland if contaminated foods are ingested or
radioactive materials in the air are inhaled, causing hypothy-
roidism and acute thyroiditis. Stochastic effect, also named the
chronic health effect, can affect people as far as 500 kilome-
ters away. It is not closely dose-dependent, but possibility of
thyroid cancer and autoimmune thyroiditis increases with
increasing radiation exposure.
People at high risk of radioactive iodine exposure should
take stable iodine before exposure or as early as possible. The
mechanism is the Wolff-Chaikoff effect, to inhibit the thyroid
gland for uptake of radioactive iodine. When large amount of
iodine is given, iodopeptides are formed, which would1726-4901/$ - see front matter Copyright  2011 Elsevier Taiwan LLC and the C
doi:10.1016/j.jcma.2011.06.010temporarily inhibit thyroid peroxidase mRNA and protein
synthesis and, therefore, thyroglobulin iodinations.3 Inhibition
of intrathyroidal dehalogenation by iodide was also observed
on animals.4 According to the World Health Organization
guideline of iodine prophylaxis against nuclear accident,
children and adolescents are the most radioactive iodine
sensitive group, but their side effects to stable iodine are
minimal.5 When avertable dose of 10 mGy (Gray) to the
thyroid gland is estimated, stable iodine prophylaxis for chil-
dren and adolescents is recommended. Adults, however, are
less radioactive iodine sensitive, and their side effects to stable
iodine are larger than that of the children. Therefore, avertable
dose to the thyroid, only more than 100 mGy, is recommended
for stable iodine prophylaxis. For adults older than 40 years,
their risk of developing radiation thyroid cancer is minimal,
and their side effects to iodine could be severe. Stable iodine
prophylaxis to adult, older than 40 years, is generally
not recommended, except estimated dosage exposure above
5 Gy.
The side effects of stable iodine are usually not serious.
Skin rash, salivary gland enlargement, oral burning sensation,
gingival soreness, gastrointestinal discomfort, and diarrhea are
the minor side effects. Allergic responses to iodine includes
fever, arthralgia, facial swelling.6 People with active thyroid
disease such as Graves’ disease should not take iodine
prophylaxis, and people with known iodine hypersensitivity,
dermatitis herpetiformin, and hypocomplementemia vasculitis
should also avoid stable iodine intake. The recommended
daily doses are 100 mg for adults and adolescents, 50 mg for
children aging 3e12 years, 25 mg for infants aging 1 month to
3 years, and neonates (birth to 1 month) 12.5 mg.5
As residents in Taiwan, protection against deterministic
effect is not necessary because of the long distance from
Japan. However, protection against stochastic effect is
important, and we should reduce the risk as low as reasonably
achievable. In Taiwan, the possible source of radiation are
radioactive cloud, food and water contaminations. Before the
radioactive cloud arrives, sheltering is the first priority. It is
only when the estimated exposure dosage exceeds the World
Health Organization recommended interventional level, we
should take stable iodine. Food control and regulation are
better than stable iodine intake because the side effects of
stable iodine increase with dosage and there is escape effecthinese Medical Association. All rights reserved.
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educate people, when and how to take stable iodine, and those
people with contraindication to iodine who should not take it.
Voluntary purchase of stable iodine should be allowed, and the
government should tell the public where they can get the
stable iodine and the timings to take it.
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